Diploma (LON:DPLM - Get Free Report) had its price objective hoisted by investment analysts at Berenberg Bank from GBX 5,750 to GBX 6,350 in a report released on Wednesday,Digital Look reports. The firm currently has a "buy" rating on the stock. Berenberg Bank's target price suggests a potential upside of 15.14% from the company's current price.
Other equities analysts have also issued research reports about the stock. Shore Capital restated a "hold" rating and set a GBX 5,100 price objective on shares of Diploma in a research report on Thursday, July 17th. JPMorgan Chase & Co. restated a "neutral" rating and set a GBX 4,440 price objective on shares of Diploma in a research report on Wednesday, August 6th. Finally, Jefferies Financial Group raised their price objective on shares of Diploma from GBX 4,500 to GBX 5,200 and gave the company a "hold" rating in a research report on Thursday. Two analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to MarketBeat, Diploma presently has a consensus rating of "Hold" and a consensus target price of GBX 5,238.
Get Our Latest Research Report on DPLM
Diploma Stock Performance
Shares of DPLM opened at GBX 5,515 on Wednesday. The firm has a 50-day moving average price of GBX 5,260.35 and a 200 day moving average price of GBX 4,609.28. The firm has a market capitalization of £7.39 billion, a PE ratio of 4,436.85, a P/E/G ratio of 2.82 and a beta of 0.75. The company has a quick ratio of 0.80, a current ratio of 2.17 and a debt-to-equity ratio of 62.17. Diploma has a 52-week low of GBX 3,532 and a 52-week high of GBX 5,625.
Diploma Company Profile
(
Get Free Report)
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Diploma, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diploma wasn't on the list.
While Diploma currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
